TODAY2 Phase 2 Follow-up

CompletedOBSERVATIONAL
Enrollment

517

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

January 17, 2020

Study Completion Date

January 17, 2020

Conditions
Type 2 Diabetes
Interventions
OTHER

TODAY cohort

This protocol is observation only and involves no intervention, care, treatment, or management.

Trial Locations (15)

10032

Columbia University Naomi Berrie Diabetes Center, New York

13210

SUNY Upstate New York University, Syracuse

15224

Children's Hospital of Pittsburgh, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

44106

Case Western Reserve University Rainbow Babies and Children's Hospital, Cleveland

63104

Saint Louis University, St Louis

63110

Washington University, St Louis

73104

University of Oklahoma Health Science Center, Oklahoma City

77030

Baylor College of Medicine, Houston

78229

University of Texas Health Sciences Center, San Antonio

80045

University of Colorado Denver Children's Hospital, Aurora

90027

Children's Hospital Los Angeles, Los Angeles

06520

Yale University School of Medicine Department of Pediatrics, New Haven

02114

Massachusetts General Hospital, Boston

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Eye Institute (NEI)

NIH

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT02310724 - TODAY2 Phase 2 Follow-up | Biotech Hunter | Biotech Hunter